The experience that we and many other groups have had is that there are many individuals with high levels of antibodies who do not have the “classical” symptomatology of the so-called MCTD, and likewise, there are patients with these symptoms who have either low titres or no evidence of anti-RNP antibodies. The gene discussed is RNPC3; the disease is mixed connective tissue disease.